scholarly journals Current Status and Survival Impact of Infectious Disease Consultation for Multidrug-Resistant Bacteremia in Ventilated Patients: A Single-Center Experience in Korea

2018 ◽  
Vol 33 (2) ◽  
pp. 73-82 ◽  
Author(s):  
Insu Kim ◽  
Won-Young Kim ◽  
Eun Suk Jeoung ◽  
Kwangha Lee
Keyword(s):  
Infectious Disease ◽  
Multidrug Resistant ◽  
Current Status ◽  
Single Center ◽  
Single Center Experience ◽  
Infectious Disease Consultation ◽  
Ventilated Patients

scholarly journals Development and current status of electrophysiology in Croatia — insights from a 5-year single-center experience

2014 ◽  
Vol 9 (9-10) ◽  
pp. 361-361
Author(s):  
Sime Manola ◽  
Ivan Zeljkovic ◽  
Ivica Benko ◽  
Vjekoslav Radeljic ◽  
Nikola Pavlovic
Keyword(s):  
Current Status ◽  
Single Center ◽  
Single Center Experience

Multidrug Resistant Bacterial Isolates in Hematopoietic Stem Cell Recipients-Single Center Experience

2019 ◽  
Vol 19 ◽  
pp. S262-S263
Author(s):  
Zlate Stojanoski ◽  
Aleksandra Pivkova-Veljanovska ◽  
Irina Panovska-Stavridis ◽  
Lidija Cevreska ◽  
Lazar Cadievski ◽  
...  
Keyword(s):  
Stem Cell ◽  
Hematopoietic Stem Cell ◽  
Multidrug Resistant ◽  
Bacterial Isolates ◽  
Single Center ◽  
Hematopoietic Stem ◽  
Single Center Experience

scholarly journals Ceftolozane/Tazobactam and Ceftazidime/Avibactam for Multidrug-Resistant Gram-Negative Infections in Immunocompetent Patients: A Single-Center Retrospective Study

Antibiotics ◽  
2020 ◽  
Vol 9 (10) ◽  
pp. 640
Author(s):  
Rosario Cultrera ◽  
Marco Libanore ◽  
Agostino Barozzi ◽  
Erica d’Anchera ◽  
Letizia Romanini ◽  
...  
Keyword(s):  
Life Experiences ◽  
Real Life ◽  
Multidrug Resistant ◽  
Empirical Treatment ◽  
Baseline Risk ◽  
Single Center ◽  
Gram Negative ◽  
Single Center Experience ◽  
Carbapenem Resistant ◽  
Tract Infections

Complicated infections from multidrug-resistant Gram-negative bacteria (MDR-GNB) represent a serious problem presenting many challenges. Resistance to many classes of antibiotics reduces the probability of an adequate empirical treatment, with unfavorable consequences, increasing morbidity and mortality. Readily available patient medical history and updated information about the local microbiological epidemiology remain critical for defining the baseline risk of MDR-GNB infections and guiding empirical treatment choices, with the aim of avoiding both undertreatment and overtreatment. There are few literature data that report real-life experiences in the use of ceftolozane/tazobactam and ceftazidime/avibactam, with particular reference to microbiological cure. Some studies reported experiences for the treatment of MDR-GNB infections in patients with hematological malignancies or specifically in Pseudomonas aeruginosa infections. We report our clinical single-center experience regarding the real-life use of ceftolozane/tazobactam and ceftazidime/avibactam to treat serious and complicated infections due to MDR-GNB and carbapenem-resistant Enterobacterales (CRE), with particular regard given to intra-abdominal and urinary tract infections and sepsis.

Sign in / Sign up

Export Citation Format

Share Document